Income statement
USD
Annual
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 14M | 11M | 16M | 14M | 20M |
| Gross Profit | 14M | 11M | 16M | 14M | 20M |
| Operating Income | 12M | 9M | 13M | 10M | 16M |
| EBITDA | 1M | -31M | 7M | -17M | -5M |
| Net Income | 13M | -22M | 20M | -7M | 11M |
| EPS (Diluted) | — | — | — | — | — |
Financial Services
Live Price
Offline$9.83
+0.00% today
Window Change
-0.51%
Window
Jun 23, 2025 → May 14, 2026
Coverage: 226 bars · Jun 23, 2025 → May 14, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Shenkman Capital Short Duration High Income Fund (SCFFX) is a fund with a market cap of $2.10B and listed on NASDAQ. The fund last traded around $9.83 and down 0.5% across the available one-year price window (Jun 23, 2025 → May 14, 2026). Baseline metrics include a dividend yield of 5.3%, a 50-day average of $9.82, a 200-day average of $9.87. Valuation already assumes a fairly strong business story at price/sales 148.1. Stock Foundry combines SCFFX price history, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SCFFX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SCFFX Max Drawdown
-2.01%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SCFFX and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$19.8M
+44.9% YoY
FY Net Income
$11.0M
+260.1% YoY
Free Cash Flow
$9.3M
-78.6% YoY
Revenue Growth
+28.4%
EPS Growth
+160.7%
Gross Margin
100.0%
Net Margin
93.6%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 14M | 11M | 16M | 14M | 20M |
| Gross Profit | 14M | 11M | 16M | 14M | 20M |
| Operating Income | 12M | 9M | 13M | 10M | 16M |
| EBITDA | 1M | -31M | 7M | -17M | -5M |
| Net Income | 13M | -22M | 20M | -7M | 11M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3M | 2M | 4M | 1M | 3M |
| Total Assets | 192M | 197M | 244M | 295M | 354M |
| Total Liabilities | 51M | 56M | 65M | 59M | 95M |
| Shareholder Equity | 141M | 141M | 179M | 237M | 260M |
| Total Debt | 26M | 32M | 43M | 55M | 85M |
| Net Debt | 23M | 30M | 39M | 54M | 82M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
9M
-78.6% YoY
Capital Expenditures
0
Free Cash Flow
9M
-78.6% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
85.3%
Net Margin
93.6%
ROE
9.4%
Debt / Equity
0.18x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.